Dara Wright - 01 Sep 2021 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Reporting relationship: Executive Vice President
Issuer ticker: BIO
Reported as of: 01 Sep 2021
Net transaction value: -$123,866
SEC form: 4
Accepted by SEC: 03 Sep 2021, 17:08:19 UTC
Next SEC filing: 17 Dec 2021
Source filing: View source filing
Reporting owner signature: /s/ Dara Wright

Filing notes and source

Key filing fact

Dara Wright filed Form 4 for BIO-RAD LABORATORIES, INC. (BIO) on 03 Sep 2021.

Key facts

This page summarizes Dara Wright's Form 4 filing for BIO-RAD LABORATORIES, INC. (BIO).
5 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 03 Sep 2021, 17:08.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: -$123,866.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BIO transaction

Bio-Rad A Common Stock

Options Exercise

Transaction value: $0
Shares: +433
Change %: +132%
Price: $0.000000
Shares after: 761
Date: 02 Sep 2021
Ownership: Direct
Footnotes: F1

BIO transaction

Bio-Rad A Common Stock

Tax liability

Transaction value: $123,866
Shares: -150
Change %: -20%
Price: $825.77
Shares after: 611
Date: 02 Sep 2021
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BIO transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +1,621
Change %
Price: $0.000000
Shares after: 1,621
Date: 01 Sep 2021
Ownership: Direct
Underlying class: Bio-Rad A Common Stock
Underlying amount: 1,621
Exercise price: $0.000000
Footnotes: F2, F3

BIO transaction Derivative

Non-Qualified Stock Option (right to buy)

Award

Transaction value: $0
Shares: +1,621
Change %
Price: $0.000000
Shares after: 1,621
Date: 01 Sep 2021
Ownership: Direct
Underlying class: Bio-Rad A Common Stock
Underlying amount: 1,621
Exercise price: $814.95
Footnotes: F4

BIO transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -433
Change %: -25%
Price: $0.000000
Shares after: 1,300
Date: 02 Sep 2021
Ownership: Direct
Underlying class: Bio-Rad A Common Stock
Underlying amount: 433
Exercise price: $0.000000
Footnotes: F2, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Shares of Class A common stock acquired on the vesting of restricted stock units.

Footnote F2

Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

Footnote F3

The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.

Footnote F4

The stock option vests over four years at 25% per year on the yearly anniversary date of the grant.

Footnote F5

On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.